An in vivo small-molecule drug screen in developing zebrafish larvae identifies dozens of unique chemical modulators capable of reducing atherogenic apolipoprotein B levels.

For centuries, scientists have been fascinated by the remarkable coordinated movements of flocking birds, swarming insects ...